TNFRSF8 and mature T-cell and NK-cell non-Hodgkin lymphoma: Differentiating ALCL from other CD30+ lymphomas, such as HL, PTCL, and Mycosis Fungoides (MF), is critical due to differences in treatment approaches and prognosis.